Cellular gene expression during Hepatitis C virus replication as revealed by Ribosome Profiling by Gerresheim, Gesche K. et al.
UCC Library and UCC researchers have made this item openly available.
Please let us know how this has helped you. Thanks!
Title Cellular gene expression during Hepatitis C virus replication as revealed
by Ribosome Profiling
Author(s) Gerresheim, Gesche K.; Bathke, Jochen; Michel, Audrey M.; Andreev,
Dmitri E.; Shalamova, Lyudmila A.; Rossbach, Oliver; Hu, Pan; Glebe,
Dieter; Fricke, Markus; Marz, Manja; Goesmann, Alexander; Kiniry,
Stephen J.; Baranov, Pavel V.; Shatsky, Ivan N.; Niepmann, Michael
Publication date 2019-03-15
Original citation Gerresheim, G.K., Bathke, J., Michel, A.M., Andreev, D.E., Shalamova,
L.A., Rossbach, O., Hu, P., Glebe, D., Fricke, M., Marz, M. and
Goesmann, A., 2019. Cellular Gene Expression during Hepatitis C Virus
Replication as Revealed by Ribosome Profiling. International journal of
molecular sciences, 20(6), (1321). DOI:10.3390/ijms20061321
Type of publication Article (peer-reviewed)
Link to publisher's
version
https://www.mdpi.com/1422-0067/20/6/1321
http://dx.doi.org/10.3390/ijms20061321
Access to the full text of the published version may require a
subscription.
Rights © 2019 by the authors. Licensee MDPI, Basel, Switzerland
https://creativecommons.org/licenses/by/4.0/
Item downloaded
from
http://hdl.handle.net/10468/9038
Downloaded on 2020-06-06T01:06:21Z
 International Journal of 
Molecular Sciences
Article
Cellular Gene Expression during Hepatitis C Virus
Replication as Revealed by Ribosome Profiling
Gesche K. Gerresheim 1, Jochen Bathke 2, Audrey M. Michel 3, Dmitri E. Andreev 4,
Lyudmila A. Shalamova 5, Oliver Rossbach 6 , Pan Hu 1, Dieter Glebe 7, Markus Fricke 8,
Manja Marz 9, Alexander Goesmann 2 , Stephen J. Kiniry 3, Pavel V. Baranov 3,
Ivan N. Shatsky 4 and Michael Niepmann 1,*
1 Institute of Biochemistry, Medical Faculty, Justus-Liebig-University, Friedrichstrasse 24, 35392 Giessen,
Germany; gesche.gerresheim@gmx.de (G.K.G.); cannyhp@126.com (P.H.)
2 Bioinformatics and Systems Biology, Faculty of Biology and Chemistry, Justus-Liebig-University,
35392 Giessen, Germany; jochen.bathke@agrar.uni-giessen.de (J.B.);
Alexander.Goesmann@computational.bio.uni-giessen.de (A.G.)
3 School of Biochemistry and Cell Biology, University College Cork, Cork T12 XF62, Ireland;
audreymannion@gmail.com (A.M.M.); 114224403@umail.ucc.ie (S.J.K.); p.baranov@ucc.ie (P.V.B.)
4 Belozersky Institute of Physico-Chemical Biology, Lomonosov Moscow State University, Moscow 119234,
Russia; cycloheximide@yandex.ru (D.E.A.); ivanshatskyster@gmail.com (I.N.S.)
5 Institute for Virology, Faculty of Veterinary Medicine, Justus-Liebig University, 356392 Giessen, Germany;
ludmilashalamova@gmail.com
6 Inst. of Biochemistry, Faculty of Biology and Chemistry, Justus-Liebig-University, 35392 Giessen, Germany;
Oliver.Rossbach@chemie.bio.uni-giessen.de
7 Inst. of Medical Virology, Justus-Liebig-University, National Reference Center for Hepatitis B and D Viruses,
Giessen, and German Center for Infection Research (DZIF), partner site Giessen, 35392 Giessen, Germany;
Dieter.Glebe@viro.med.uni-giessen.de
8 Genevention GmbH, 37079 Göttingen, Germany; markus.fricke2@googlemail.com
9 RNA Bioinformatics and High Throughput Analysis, Faculty of Mathematics and Computer Science,
Friedrich Schiller University Jena, 07743 Jena, Germany; manja@uni-jena.de
* Correspondence: michael.niepmann@biochemie.med.uni-giessen.de; Tel.: +49-(0)641-9947471
Received: 31 January 2019; Accepted: 12 March 2019; Published: 15 March 2019


Abstract: Background: Hepatitis C virus (HCV) infects human liver hepatocytes, often leading
to liver cirrhosis and hepatocellular carcinoma (HCC). It is believed that chronic infection alters
host gene expression and favors HCC development. In particular, HCV replication in Endoplasmic
Reticulum (ER) derived membranes induces chronic ER stress. How HCV replication affects host
mRNA translation and transcription at a genome wide level is not yet known. Methods: We used
Riboseq (Ribosome Profiling) to analyze transcriptome and translatome changes in the Huh-7.5
hepatocarcinoma cell line replicating HCV for 6 days. Results: Established viral replication does not
cause global changes in host gene expression—only around 30 genes are significantly differentially
expressed. Upregulated genes are related to ER stress and HCV replication, and several regulated
genes are known to be involved in HCC development. Some mRNAs (PPP1R15A/GADD34,
DDIT3/CHOP, and TRIB3) may be subject to upstream open reading frame (uORF) mediated
translation control. Transcriptional downregulation mainly affects mitochondrial respiratory
chain complex core subunit genes. Conclusion: After establishing HCV replication, the lack of
global changes in cellular gene expression indicates an adaptation to chronic infection, while the
downregulation of mitochondrial respiratory chain genes indicates how a virus may further contribute
to cancer cell-like metabolic reprogramming (“Warburg effect”) even in the hepatocellular carcinoma
cells used here.
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1. Introduction
Hepatitis C Virus (HCV) causes liver disease by preferentially infecting human liver
hepatocytes [1]. Acute HCV infections remain asymptomatic in most cases and the virus is cleared,
whereas only in rare cases, patients develop acute life-threatening liver disease. However, in about
60–80% of infected persons the virus is not eliminated but continues to chronically replicate in the liver.
Worldwide, about 71 million people are chronic carriers of HCV, of which about 15–30% develop liver
cirrhosis within 20 years [2,3], which finally may lead to hepatocellular carcinoma (HCC). Among those
chronic HCV patients who underwent anti-HCV treatment, the incidence of HCC is about 1–2% per
year, but with increasing age the incidence can be as high as 10% per year [4,5]. Although powerful
direct-acting antivirals (DAAs) have now been available for years, the high costs of treating chronic
HCV infection by DAAs, as well as the emergence of resistant-virus isolates remain serious problems
of disease control and underline the persisting need for a better understanding of cellular changes
during HCV infection and disease development [6,7]. In particular, HCC recurs with a very high
incidence even after successful clearance of HCV [4].
HCV belongs to the family Flaviviridae and has a positive-sense single-stranded RNA genome of
about 9600 nucleotides (Figure 1A) [8]. The infectious virus comes as an enveloped lipoviral particle
that contains viral proteins as well as cellular lipids and proteins [1,9,10]. The hepatotropism of HCV
is in part due to a variety of receptors bound by the virus [1]. After infection of the cell, the HCV
RNA genome is translated in the cytoplasm by virtue of an internal ribosome entry site (IRES) element
located in its 5′ leader (for a review see [11]). Viral proteins which are processed from the precursor
polyprotein then induce the formation of double membrane vesicles that derive from the endoplasmic
reticulum (ER) and form a so-called membranous web which provides a protected environment
for replication of the viral RNA [10,12]. The liver-specific microRNA-122 (miR-122) is involved in
enhancing replication, translation, and stability of the HCV genome [13–15] and by that considerably
contributes to the hepatotropism of HCV.
The highly conserved RNA secondary structure and sequence cis-elements involved in genome
replication are located near the genome ends as well as in the protein coding region [8,11,16–18].
The infecting viral plus-strand RNA genome is copied to produce an antigenome minus strand by
virtue of the replication complex including the viral non-structural (NS) proteins NS3-NS5B. From
this minus strand, progeny plus strands are then produced in large excess [16]. After that, translation
from the progeny plus strand genomes produces large amounts of viral proteins [16,19], and finally
the viral progeny genomes are encapsidated into newly assembling viruses [9,10,20,21]. HCV particle
assembly not only involves viral proteins but also cellular proteins, in particular some of which are
involved in the metabolism of very low density lipoprotein (VLDL) and low density lipoprotein (LDL)
particles that are routinely synthesized by the hepatocytes to deliver various lipids to other organs.
Proteins involved are in particular the apolipoproteins ApoE, ApoAI, ApoCII, and ApoB [9].
Upon HCV infection, the expression of cellular genes is subject to various changes.
HCV replication in the ER-derived membranes causes ER stress [22]. Several mechanisms of the
innate and adaptive immune system are activated [23–25]. However, the virus counteracts many of
these steps by interactions of its proteins with components of the cellular innate immune system, often
leading to failure of the innate immune response in HCV infection [23,24]. Also, the adaptive immune
response, e.g., by cytotoxic T cells, often fails [23,24]. Moreover, fast generation of HCV escape mutants
due to its error-prone replicase is among the reasons that the adaptive immune response is unable to
keep pace with the molecular evolution of HCV [25].
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Figure 1. Hepatitis C Virus (HCV) replication in Huh‐7.5 cells. (A) Full‐length HCV genomes were 
transfected into Huh‐7.5 cells. Six days after transfection, replication of HCV in the cells was assessed 
by detection of HCV NS3 protein (200‐fold magnification) (B), HCV genomic RNA and miR‐122 (C) 
as  well  as  HCV  NS3  and  Core  proteins  by  Western  Blot.  GAPDH  (glycerol‐3‐phosphate 
dehydrogenase) was analyzed as loading control (D). (E) Cytoplasmic cell extracts were subjected to 
sucrose gradient centrifugation in order to enrich 80S ribosomes. 
Metagene analysis of reads representing all RNAs in the cell (Figure 2B, panels “RNA”) shows 
that reads are distributed evenly over coding regions of mRNAs, and 3´UTRs (right panels) are longer 
than 5´UTRs (left panels) on average. Ribosome occupancy (panels “Ribo”) shows a small peak at the 
start site, which may, however, in part be due to sequence biases since peaks in the RNAseq profiles 
coincide with the start. Moreover, a “ramp” of ribosomes queuing in the first 100 nucleotides of the 
coding sequence is observed, which may be due to ribosomes queuing downstream of the start codon 
as to be expected [38]. Then follows a rather even distribution of ribosomes over the remaining coding 
sequence and a sharp decrease in read numbers downstream of the stop codon. All these metagene 
analysis results are as expected and thus serve as a quality control. The results also show that HCV 
replication does not drastically change the relative distribution of ribosomes on the cellular mRNAs.   
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Developme t of hepatocellular carcinoma as a consequence of chronic HCV infection is yet
far f om being compl tely understood [26–28]. Cellular changes that may contribute to ca c
development include scape from immune responses as described above, evasion fro the control of
growth and tumor suppressors, escape from apoptosis, genome instability nd mutation, inducti n of
angiogenesis, proliferative signaling as well as metabolic reprogramming [28–30] and the deregulation
of cellular energetics. Mitochondrial bioenerg ic imbalance has been shown to be du to calcium
ion influ that is caused by the ER modifications at ER-mit chondrial fusion r gions indu e by
HCV proteins, without providing a direct link to mitochondrial gene ex ressi [31,32]. In addition,
HCV core pro ein was shown to con ribut to mitochondrial damage by impairing mitophagy [33].
Both mechanisms (and o hers) result in enhanced oxidative stress in the mitochondria and by that
contribute to carcinogenesis.
In this study, we aimed to detect changes in cellular gene expression due to transcriptional as well
as translational control after ongoing HCV replication was fully established in the cells. To this end,
we analyzed cellular expression changes 6 days after the onset of HCV infection. Even though the use
of Huh-7.5 hepatocarcinoma cells in our study already comes with the limitation that we could not
observe a full change from primary liver hepatocyctes to HCC cells, our results show the upregulation
of genes involved in ER stress, autophagy, metabolic reprogramming and further contribution to
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HCC development. Translation of some of these mRNAs may involve regulatory upstream open
reading frames (uORFs). Moreover, downregulation of several mitochondrial respiratory chain key
genes indicates a downregulation of oxidative phosphorylation, a novel possible contribution to the
development of the Warburg effect that enhances metabolite flux in cancer cells despite ongoing
oxidative phosphorylation.
2. Results and Discussion
2.1. Gene Expression Analysis in Cells Replicating HCV
We have chosen the popular model of Huh-7.5 hepatocarcinoma cell line which is fully capable
to support all stages of the viral life cycle. The cells were transfected with full-length HCV genomes
(Figure 1A) and allowed to replicate and spread the virus for 6 days. This protocol was chosen in
order to approach conditions of chronic HCV replication in cells. A full replication cycle of HCV takes
less than 24 h [34]. Therefore, after 6 days all cells are infected by the virus (Figure 1B), the HCV
genomes have undergone multiple rounds of replication, and the situation in the cells can be regarded
to mimic fully established ongoing HCV replication that resembles chronic HCV infection. Cellular
miR-122 concentrations were similar in all HCV and mock transfected replicates (Figure 1C, left panel),
while HCV RNA (Figure 1C, right panel) and HCV proteins (Figure 1D) were detected only in
HCV-transfected cells.
We then analyzed both the transcriptional as well as the translational regulation of mRNAs
in the HCV replicating cells. Therefore, we isolated total RNA from the cells to analyze transcript
abundance by next generation sequencing (NGS). In parallel, we isolated the RNA fragments occupied
by ribosomes using the ribosome profiling method [35,36]. In addition to the Ingolia protocol [36],
we enriched 80S ribosomes by sucrose gradient centrifugation (Figure 1E, “80S”) to ensure that we
selectively capture RNA that actually is occupied by ribosomes [37], in contrast to other RNA that may
have been unspecifically pelleted in aggregates.
Overall analysis of cellular gene expression by principal component analysis (PCA; Figure 2A)
shows that mRNA expression in the triplicates of HCV replicating cells closely clusters separately from
the cluster of mock-transfected cells (“RNA”, right). Reads representing ribosome occupancy (“Ribo”,
left) largely differ from those of mRNA abundance, and also here HCV replicating cells differ from
mock-transfected cells. In the ribosome profiling analyses, one of the replicates of each treatment is
somewhat separate from the other two in the PCA plot. Therefore, in further analyses (see below) we
have tested differential gene expression by comparing each of the three replicates of one treatment
(e.g., HCV) against each replicate of the other treatment (mock) in all possible crosswise combinations.
In these analyses, the results were very similar also when each one of the replicates was omitted from
the analysis (not shown). Due to the robustness of these results we conclude that downstream gene
expression analysis yields a reliable representation of the differences in gene expression and ribosome
occupancy between the different treatments.
Metagene analysis of reads representing all RNAs in the cell (Figure 2B, panels “RNA”) shows
that reads are distributed evenly over coding regions of mRNAs, and 3´UTRs (right panels) are longer
than 5´UTRs (left panels) on average. Ribosome occupancy (panels “Ribo”) shows a small peak at the
start site, which may, however, in part be due to sequence biases since peaks in the RNAseq profiles
coincide with the start. Moreover, a “ramp” of ribosomes queuing in the first 100 nucleotides of the
coding sequence is observed, which may be due to ribosomes queuing downstream of the start codon
as to be expected [38]. Then follows a rather even distribution of ribosomes over the remaining coding
sequence and a sharp decrease in read numbers downstream of the stop codon. All these metagene
analysis results are as expected and thus serve as a quality control. The results also show that HCV
replication does not drastically change the relative distribution of ribosomes on the cellular mRNAs.
Int. J. Mol. Sci. 2019, 20, 1321 5 of 19
Int. J. Mol. Sci. 2019, 20, x FOR PEER REVIEW  5  of  19 
 
 
Figure 2. Quality controls of transcriptome and ribosome profiling analyses. (A) Principal component 
analysis (PCA) of gene expression in transcriptome and ribosome profiling replicates. (B) Metagene 
analyses of transcriptome reads (“RNA”) and ribosome profiling reads (“Ribo”) in HCV‐replicating 
cells and non‐transfected cells (“Mock”) around the Start and Stop codons of cellular mRNAs. 
2.2. Established Viral Replication Does Not Cause Global Changes in Host Gene Expression 
Comprehensive analyses of changes in cellular transcription in HCV replicating Huh‐7.5 cells 
compared to non‐infected cells show that the average transcription level of most mRNAs does not 
significantly change during HCV replication compared to non‐infected cells. Only around 30 genes 
are differentially expressed. Fourteen mRNAs are significantly upregulated on  the  transcriptional 
level (Figure 3A), while even only six mRNAs are significantly downregulated. Analysis of ribosome 
occupancy of the cells by ribosome profiling shows upregulation of only very few mRNAs (Figure 
3C).  Sixteen  RNAs  are  significantly  upregulated  and  only  three  downregulated, many  of  them 
overlapping  with  those  upregulated  already  on  the  transcriptional  level.  In  conclusion,  after 
establishing HCV  replication  in  the  cells,  chronic HCV  replication  avoids  global  changes  in  the 
transcriptome and translatome.   
Fig re 2. ality co trols of tra scri to e a riboso e rofili g a alyses. ( ) ri ci al co o e t
l sis ( ) f e e e ressi i tr scri t e ri s e r fili re lic tes. ( ) et e e
l s s f tr scri t r s ( ) ri s r fili r s ( i ) i -r lic ti
ll -t f t ll ( ) t t t t f ll l r s.
2.2. Established Viral Replication Does Not Cause Global Changes in Host Gene Expression
Co prehensive analyses of changes in cellular transcription in HCV replicating Huh-7.5 cells
co pared to non-infected cells show that the average transcription level of ost RNAs does not
significantly change during HCV replication co pared to non-infected cells. Only around 30 genes
are differentially expressed. Fourteen RNAs are significantly upregulated on the transcriptional
level (Figure 3A), while even only six RNAs are significantly downregulated. Analysis of riboso e
occupancy of the cells by ribosome profiling shows upregulation of only very few mRNAs (Figure 3C).
Sixteen RNAs are significantly upregulated and only three downregulated, many of the overlapping
with those upregulated already on the transcriptional level. In conclusion, after establishing
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HCV replication in the cells, chronic HCV replication avoids global changes in the transcriptome
and translatome.
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Figure 3. Gene expression in HCV‐transfected versus mock‐transfected cells 6 days after transfection, 
analyzed with the Differential plot in Trips‐Viz [39]. (A) Transcriptome analysis (“RNA”). The x‐axis 
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3, window size 25–40 bp) normalized by mapped reads,  the y‐axis  the average  log(2)‐fold change 
(LFC)  of  expression. The  black  line  indicates LFC  =  0. The  yellow  lines  indicate  the  significance 
threshold. Significantly upregulated genes are shown in green, downregulated genes in red. DDIT3 
was  under  the  read  count  threshold  but  is  noted  in  the  plot.  (B)  Downregulation  values  of 
mitochondrial genes in detail. (C) Ribosome profiling analysis (“Ribo”). Details are as in (A), but reads 
were counted in the coding sequence only. 
Some  well‐known  genes  are  highly  expressed.  Alpha‐fetoprotein  (AFP)  is  preferentially 
expressed  in  fetal and neonatal but not  in adult  liver. However, expression of AFP  is  reactivated 
during  adult  liver  regeneration  and  hepatocarcinogenesis  [40].  Thus,  the  high  AFP  expression 
Figure 3. Gen xpression in HCV-transfected -tr sfected cells 6 days afte transfection,
an lyzed with the Differ ntial plot in Trips-Viz [39]. ( e analysis (“RNA”). The x-axis
denotes the log(2) of geometric mean read counts in complete mRNAs (mini u n r f r s 3,
window size 25–40 bp) normalized by mapped reads, the y-axis the average log(2)-fold change (LFC)
of expression. The black line indicates LFC = 0. The yellow lines indicate the significance threshold.
Significantly upregulated genes are shown in green, downregulated genes in red. DDIT3 was under
the read count threshold but is noted in the plot. (B) Downregulation values of mitochondrial genes in
detail. (C) Ribosome profiling analysis (“Ribo”). Details are as in (A), but reads were counted in the
coding sequence only.
Only very few genes were found to be transcriptionally downregulated (Figure 3A). One of them
is arginase 1 (ARG1), an important enzyme of the urea cycle in hepatocytes. Its activity of releasing urea
from arginine is key to controlling the overall release of nitrogen from the body. It may be tempting to
speculate if the downregulation of arginase may contribute to saving amino acids for HCV replication
and tumor growth. Two other genes that are strongly downregulated on the translational level are
H3F3A (H3 Histone Family Member 3A) and SNRPG (Small Nuclear Ribonucleoprotein Polypeptide
G) (Figure 3C).
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Some well-known genes are highly expressed. Alpha-fetoprotein (AFP) is preferentially expressed
in fetal and neonatal but not in adult liver. However, expression of AFP is reactivated during adult
liver regeneration and hepatocarcinogenesis [40]. Thus, the high AFP expression observed here
can be regarded as a tumor cell marker of the Huh-7.5 hepatocarcinoma cells. In contrast, several
highly expressed genes are characteristic for liver cells, like serum albumin (ALB). Apolipoprotein B
(ApoB) is expressed in liver cells for the routine production of VLDL and LDL particles that serve to
transport lipids to the body´s periphery [41]. Other typical liver proteins involved in lipid metabolism
like ApoA1, ApoA2, and fatty acid synthase (FASN) (Figure 3A, C) but also ApoC1, ApoC2, ApoC3,
and ApoM (not shown) are expressed in the cells, indicating that the Huh-7.5 hepatocarcinoma cells
retain a hepatocyte-like metabolic state, while their expression levels did essentially not change upon
HCV replication. Also ApoE, which is involved in HCV particle assembly [21,42], is highly expressed
in the Huh-7.5 cells. Some genes related to ER stress and hepatocellular carcinogenesis are upregulated
(see below). However, we did not find significant differential expression of innate immune response
genes, interferon-stimulated genes (ISGs) or changes in mTOR dependent translation. This suggests
that HCV successfully counteracts persistent changes in gene expression of cellular defense genes.
2.3. Key Mitochondrial Respiratory Chain Genes Are Downregulated
The other genes that are significantly downregulated on the transcriptional level code for subunits
of the mitochondrial respiratory chain complex I (NADH-ubiquinone oxidoreductase) and complex
IV (cytochrome c oxidase) (Figure 3A,B), while translational regulation of mitochondrial genes was
essentially not captured by ribosome profiling due to the enrichment of cytoplasmic 80S ribosomes
during sucrose gradient centrifugation. MT-ND1, MT-ND3, MT-ND4, and MT-ND4L constitute core
subunits of complex I which are located directly within the inner mitochondrial membrane and are
involved in the enzymatic activity of the complex [43,44]. Similarly, MT-CO2 is a catalytically essential
core subunit of complex IV, and also this subunit is located directly within the inner mitochondrial
membrane [45]. Since these highly hydrophobic membrane proteins are essential components of the
mitochondrial redox metabolism, they are encoded by mitochondrial genomes but not by nuclear genes
to allow for short regulatory gene expression circuits [46], and their codon composition is markedly
different from that of average nuclear genes [47].
The early downregulation of key mitochondrial respiratory chain genes may further contribute
to the “Warburg effect” in the tumor cells [29,30,48,49]. The Warburg effect, also called “aerobic
glycolysis”, means that in tumor cells the metabolite flux through the glycolysis and pentose phosphate
pathways is strongly increased, while mitochondrial functions including oxidative phosphorylation
are still required [29,30,48,49]. This adaptation is thought to be established to provide more metabolites
for tumor cell growth, while this idea appears somewhat inconsistent with the high release of lactate
by these cells. However, some reports have linked the downregulation of oxidative phosphorylation
in mitochondria to the decreased expression of the catalytic β subunit of the F1 ATPase protein [50,51].
This could mean that the downregulation of oxidative phosphorylation and the upregulation of
glycolysis may also be an adaptation to low oxygen supply in fast growing tumors lacking sufficient
neovascularization. Moreover, mitochondrial bioenergetic imbalance during HCV infection has also
been attributed to calcium ion influx that is caused by the ER modifications at ER-mitochondrial
fusion regions induced by HCV proteins, without providing a direct link to mitochondrial gene
expression [31,32], and HCV core protein was shown to contribute to mitochondrial damage by
impairing mitophagy [33]. Our results shown here support the idea that downregulation of
mitochondrial respiratory chain activity upon active HCV replication in the cells may further contribute
to the Warburg effect, even though the Huh-7.5 cell line used here already is a hepatocarcinoma cell
line. The changes of expression of these candidate genes can be evaluated in future studies in more
physiological models of HCV infection (e.g., in primary hepatocyte cultures).
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2.4. Upregulated Genes Are Related to ER Stress, HCV Replication, and Hepatocarcinogenesis
A limited number of genes is upregulated significantly (Figure 3A,C). The 22 upregulated genes
include one (DAB2/DOC-2, clathrin adaptor protein) which is involved in a variety of signaling
processes related to endocytosis [52], and 10 genes are known to be upregulated in response to ER
stress (ANKRD1, ASNS, BMP2, DDIT3, GDF15, INHBE, PPP1R15A, SESN2, SLC3A2, and TRIB3).
The latter may be due to the heavy changes that HCV replication applies to the ER in order to organize
its replication [9,10,12].
ANKRD1 (Ankyrin Repeat Domain 1) was shown to be upregulated during HCV infection
by HCV NS5A protein and positively regulates HCV Entry [53]. ASNS (asparagine synthetase,
glutamine-hydrolyzing) is known to be transcriptionally upregulated by ER stress or conditions of
amino acid starvation [54]. BMP2 (BDA2, bone morphogenetic protein 2) is involved in the induction of
osteoblast differentiation [55]. DDIT3 (CHOP; DNA Damage Inducible Transcript 3) is implicated in the
regulation of autophagy and apoptosis [56]. GDF15 (growth differentiation factor 15) is a member of the
transforming growth factor-β cytokine superfamily. GDF15 was induced in hepatocarcinoma cells by
HCV and resulted in increased DNA synthesis, promoted cell proliferation, and enhanced invasiveness
of the cells [57]. The beta E subunit of the transforming growth factor-β (TGF-β) superfamily members
inhibin or activin (INHBE) is known to be upregulated as a transcriptional target gene of ATF4 [58].
INHBE mRNA is predominantly expressed in liver, and it may inhibit cellular proliferation and
growth [59]. Thus, in contrast to other regulated genes INHBE may counteract the induction of cell
growth in the HCV infected cell due to the induced ER stress. SESN2 (Sestrin 2) is a metabolic regulator
which plays a role in protection against oxidative and genotoxic stresses. Like SQSTM1 (see below),
it was shown to induce Nrf2-dependent metabolic reprogramming by inducing the expression of
genes for antioxidant enzymes [60]. Also the amino acid cotransporter SLC3A2 has been shown to be
induced during ER stress [61].
Two of the above genes that are upregulated by ER stress (PPP1R15A and TRIB3) as well as
three other genes (CHAC1, DUSP1, and PHLDA1) are also involved in the regulation of signaling
pathways. CHAC1 (Glutathione Gamma-Glutamylcyclotransferase 1) degrades glutathione and
thereby is involved in regulation of the oxidative balance in the cell. Glutathione depletion is an
important factor for the initiation of apoptosis. Therefore, CHAC1 acts as a pro-apoptotic component
of the unfolded protein response pathway [62]. DUSP1 (CL100, dual specificity phosphatase 1) is
involved in dephosphorylation of mitogen-activated protein (MAP) kinases [63]. PHLDA1 (Pleckstrin
Homology Like Domain Family A Member 1) is induced by ER stress and may have tissue-specific
roles in either the inhibition or elevation of cancer progression and metastasis [64].
PPP1R15A (GADD34, protein phosphatase 1 regulatory subunit 15A) is a stress-inducible subunit
of the heterodimeric eIF2α holophosphatase that antagonizes the action of eIF2α kinases [65]. During
HCV infection PPP1R15A expression is thought to counteract the stress-induced phosphorylation of
eIF2. Upon infection of primary human hepatocytes with HCV, PPP1R15A transcription was shown
to be induced, and the stress-induced phosphorylation of eIF2 and the induction of PPP1R15A led to
oscillating activity of these both proteins [22].
TRIB3 (C20orf97, tribbles pseudokinase 3) is a regulator protein that has been implicated in the
control of stress response, cell viability, and metabolic processes [66]. Under ER stress conditions,
TRIB3 is known to promote apoptosis by negatively regulating the Akt signaling pathway. While TRIB3
mRNA and protein expression levels increase in HCV-infected cells, the TRIB3-Akt signaling pathway
is disrupted by the HCV NS3 protein [67]. Thus, HCV modulates the TRIB3-Akt signaling pathway to
prevent apoptosis and establish persistent viral infection.
One of the above genes which are upregulated during ER stress (GDF15) and seven others
(AREG, CXCL5, CYR61, JUN, THBS1, UAP1L1, and SQSTM1) are known to be involved in cancer
development including particularly also HCC. CXCL5 (C-X-C Motif Chemokine Ligand 5) was shown
to promote cancer cell proliferation [68]. CYR61 (CCN1, cysteine rich angiogenic inducer 61) is
involved in the induction of lipid metabolism and a metastatic phenotype in cancer cells [69]. JUN (Jun
Int. J. Mol. Sci. 2019, 20, 1321 9 of 19
proto-oncogene, AP-1 transcription factor subunit) is involved in regulation of numerous cell activities,
such as proliferation, apoptosis, survival, tumorigenesis, and tissue morphogenesis [70]. THBS1
(thrombospondin 1) even contributes to the regulation of tumor cell adhesion, invasion, migration,
and proliferation [71].
Three of the above mentioned genes have actually been closely linked to HCV-induced
development of HCC. AREG is induced during acute and chronic liver injury, and it can protect
liver cells from apoptosis. AREG is upregulated in hepatoma cells by HCV NS3 protein and stimulates
hepatocarcinoma cell growth. Due to the activation of the cellular survival pathways, AREG may
counteract HCV-induced apoptosis of infected hepatocytes and facilitate the development of liver
cirrhosis and hepatocellular carcinoma. Moreover, AREG expression is essential for efficient HCV
assembly and virion release [72].
UAP1L1 (UDP-N-acetylglucosamine pyrophosphorylase 1 like 1) appears to be a regulator of
O-GlcNAc transferase function and is a critical factor for cell proliferation in human hepatocarcinoma
cells [73]. UAP1L1 is significantly upregulated in a distinct subset of HCC tissues, and patients with
upregulated expression of UAP1L1 appeared to have a poor prognosis [73].
Also SQSTM1 (p62, sequestosome) is upregulated in HCV replicating Huh-7.5 cells. SQSTM1
is involved in regulation of autophagy and has been found to be upregulated in HCV-positive HCC
patients [29]. SQSTM1 was reported to promote malignancy through Nrf2-dependent metabolic
reprogramming [29]. Thereby, enzymes of the pentose-phosphate pathway are upregulated, and the
concentrations of glutathione and other metabolites involved in biotransformation and drug resistance
increased, while the concentrations of metabolites of the glycolysis and the citric acid cycle were
decreased. In conclusion, the upregulation of the above genes by HCV replication even in the
hepatocarcinoma cell line Huh-7.5 indicates a further consolidation of the cancer state of these cells.
2.5. Translational Upregulation of mRNAs with Upstream Open Reading Frames
One of the most well studied stress signaling pathways which influence global protein synthesis
is phosphorylation of eIF2. It results in rapid depletion of TC (ternary complex eIF2*GTP*met-tRNAi)
levels and ultimately leads to global translational repression [74]. Some cellular mRNAs, however,
are preferentially translated under these conditions. It is believed that most of such mRNAs evade
translational repression through utilization of specific uORFs in their 5′ leaders [37]. As HCV
replication induces ER stress, it was shown that activation of eIF2 is phosphorylated in HCV infected
hepatocarcinoma cells [22].
Indeed, we observed that stress responsive DDIT3 and PPP1R15A mRNA translation is
upregulated (Figure 3C). Somewhat surprisingly, other mRNAs that are known to be differentially
regulated upon ER stress, including the archetypical example ATF4 mRNA, seem to be unchanged after
6 days of HCV replication, while translation of TRIB3 largely escapes translational downregulation.
These three mRNAs have translated upstream open reading frames (uORFs) in their 5′UTRs (Figure 4).
Stress conditions were reported to facilitate the ribosomal bypass of an inhibitory uORF in the
DDIT3 mRNA to enhance translation of the main ORF in the mouse DDIT3 mRNA [75]. A later
study from the same group reported that a ribosome stall in the uORF is involved in regulating
DDIT3 translation during the stress response. This stall is facilitated by the inhibitory amino acid
sequence Ile-Phe-Ile (I-F-I) encoded in the uORF of the mouse DDIT3 mRNA [76]. In the human
DDIT3 sequence analyzed here, we find a similar uORF arrangement (Figure 4A). The main DDIT3
ORF is in frame 1. The uORF with two in-frame start codons is in frame 2. Also in the human DDIT3
mRNA sequence, there is an I-F-I sequence four codons upstream of the uORF stop codon in frame 2.
Exactly at this position, we find a large ribosome peak in the 5´UTR of the DDIT3 mRNA (Figure 4A).
We conclude that this inhibitory I-F-I sequence also plays a major role in translation regulation of
human DDIT3/CHOP during stress response.
During HCV replication, DDIT3 is transcriptionally upregulated. Therefore, the ribosome
coverage of DDIT3 mRNA is higher due to increased mRNA abundance (red in Figure 4A). However,
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on top of this transcriptional upregulation during HCV replication, the ribosome coverage of the main
ORF in relation to the uORF again increases by an additional factor of about 2. This suggests that the
uORF with its ribosome stall site may be functionally involved in the upregulation of human DDIT3
main frame translation during the stress response. Our results show that DDIT3/CHOP is activated
during HCV-induced ER stress not only indirectly by other transcription factors [56] but also using
uORF-mediated translational regulation which actually is conferred by ribosome stalling.
Int. J. Mol. Sci. 2019, 20, x FOR PEER REVIEW  10  of  19 
 
DDIT3 main  frame  translation during  the stress  response. Our  results show  that DDIT3/CHOP  is 
activated during HCV‐induced ER stress not only indirectly by other transcription factors [56] but 
also using uORF‐mediated translational regulation which actually is conferred by ribosome stalling.   
In the PPP1R15A gene, uORFs regulate translation of the PPP1R15A main ORF during cellular 
stress [37,77]. In the mouse PPP1R15A gene, there are two uORFs in the PPP1R15A mRNA 5′UTR 
that overlap [78]. It was proposed for the mouse PPP1R15A mRNA that under normal conditions 
ribosome reinitiation on the second of the two overlapping uORFs directs translation of the second 
uORF and by  that downregulates PPP1R15A main ORF  translation. Under stress conditions, both 
uORFs are passed by scanning  ribosomes which  then start  translation at  the main ORF  initiation 
codon [78,79]. In contrast, in the human PPP1R15A gene, the two uORFs are separated. Initiation of 
the second uORF was reported to be stronger than that of the first uORF, but both uORFs are required 
for efficient downregulation of PPP1R15A main ORF translation [77].   
 
Figure 4. Detailed analysis of ribosome profiling read distribution of mRNAs regulated by upstream 
open reading frames (uORFs) during HCV replication, using Trips‐Viz single transcript comparison 
plots  [39].  (A) DDIT3  (DNA Damage  Inducible  Transcript  3),  also  named  C/EBP  Zeta  or C/EBP 
homologous protein (CHOP); Ensembl gene annotation of sliced transcripts: ENST00000346473. (B) 
PPP1R15A (protein phosphatase 1 regulatory subunit 15A), also called GADD34 (Growth Arrest and 
DNA  Damage‐Inducible),  ENST00000200453.  (C)  TRIB3  (C20orf97,  tribbles  pseudokinase  3), 
ENST00000217233.  Ribosome  profiling  read  counts  on  mRNAs  are  shown  in  blue  for  mock‐
transfected and  in red  for HCV‐transfected cells. Below  the read profiles, reading  frames counted 
from mRNA sequence entry nucleotide No. 1 are shown with start codons (small white bars) and stop 
codons (dark grey bars). A known ribosome stalling amino acid sequence (I‐F‐I) is indicated in (A). 
Fig re 4. etaile analysis of riboso e profiling rea istribution of s regulate by upstrea
o e rea i fra es ( s) ri re licatio , si ri s- iz si le tra scri t co ariso
l ts [39]. ( ) I ( a e Inducible Transcript 3), also named C/EBP Zeta or C/
l r t i (C P); Ensembl gene a notation of sliced transcripts: ENST 000346473.
(B) PPP1R15A (protein phosphatase 1 regulatory subunit 15A), also called GADD34 (Growth Arrest
and DNA Damage-Inducible), ENST 0 200453. (C) TRIB3 (C20orf97, tri bles pseudokinase ,
00000217233. Ribosome profiling read counts on mRNAs are shown in blue for mock-transfected
and in red for HCV-transfected cells. Below the read profiles, reading frames counted from mRNA
sequence entry nucleotide No. 1 are shown with start codons (small white bars) and stop codons
(dark grey bars). A known rib some stalling amino acid sequence (I-F-I) is indicated in (A).
In the PPP1R15A gene, uORFs regulate translation of the PPP1R15A main ORF during cellular
stress [37,77]. In the mouse PPP1R15A gene, there are two uORFs in the PPP1R15A mRNA 5′UTR that
overlap [78]. It was proposed for the mouse PPP1R15A mRNA that under normal conditions ribosome
reinitiation on the second of the two overlapping uORFs directs translation of the second uORF and
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by that downregulates PPP1R15A main ORF translation. Under stress conditions, both uORFs are
passed by scanning ribosomes which then start translation at the main ORF initiation codon [78,79].
In contrast, in the human PPP1R15A gene, the two uORFs are separated. Initiation of the second
uORF was reported to be stronger than that of the first uORF, but both uORFs are required for efficient
downregulation of PPP1R15A main ORF translation [77].
Our results (Figure 4B) indicate that both uORFs in the human PPP1R15A mRNA (frame 1) are
occupied by ribosomes under normal conditions as well as under conditions of HCV replication, with a
tendency for a higher ribosome occupancy of uORF1. However, under normal conditions occupation
of the stop codon of uORF2 interferes with translation initiation at the main ORF initiation codon
(in frame 3) which is too close to the uORF2 termination site. In contrast, under conditions of HCV
replication, stalling of ribosomes in the uORFs results in higher efficiency of main ORF translation.
When compared with normal conditions, under HCV replication conditions the ribosome coverage
of the main ORF is more than doubled in relation to ribosome occupancy of the uORFs. Thus, we
conclude that during HCV replication both transcriptional and translational upregulation of PPP1R15A
contribute to PPP1R15A expression.
TRIB3 mRNA also largely escapes translational downregulation (see Figure 3A,C). TRIB3 mRNA
was reported to have an inhibitory uORF in the 5′UTR [66]. The main TRIB3 ORF is in frame 2
(Figure 4C). Our inspection of the human TRIB3 mRNA sequence (ENST00000217233) revealed a
short uORF1 in frame 3 (position 129–155), followed by a second, longer uORF2 also in frame 3
(starting at position 189) with two potential stop codons (pos. 420 and 510). A strong ribosome peak at
position 510 must be attributed to termination at the second uORF2 stop codon. However, a second,
smaller ribosome peak at about position 260 in uORF2 (Figure 4C) could be speculated to be due to
ribosome stalling in the uORF2 sequence, similar to the ribosome stalling sequence in the DDIT3 uORF
(see above).
3. Conclusions
After establishment of HCV replication in the cells we observe upregulation of a limited number
of stress-induced genes. The low number of regulated genes may in part be due to the fact that the use
of Huh-7.5 hepatocarcinoma cells in this study comes with the limitation that these cells already had
undergone changes in gene expression towards cancer. HCV-regulated genes include PPP1R15A which
is counter-acting stress induction in order to normalize cellular gene expression. This may be important
for HCV to further replicate “under the radar” in order to allow chronic infection without strong
immune response. Our results also substantially add to the understanding of the downregulation of
oxidative phosphorylation in tumor cells. Downregulation of the mRNA expression coding for key
subunits of respiratory chain complexes I and IV in conjunction with the upregulation of SESN2 and
SQSTM1 occurs rather early after establishment of HCV replication in the cells. The resulting metabolic
changes in glycolysis and pentose phosphate pathway may further contribute to reprogramming the
cells towards development of hepatocellular carcinoma and establishing the Warburg effect in the
cancer cells.
4. Material and Methods
4.1. Cell Culture
Huh-7.5 cells [80] were maintained in Dulbecco’s modified Eagle medium supplemented with
10% fetal bovine serum (FBS), 100 µg/mL penicillin as well as 100 µg/mL streptomycin at 37 ◦C in
5% CO2.
4.2. In Vitro Transcription of HCV-RNA
JFH1/J6 chimeric full-length HCV genome (JC1) [34] was generated by in vitro-transcription.
Plasmids were first linearized with MluI-HF (NEB) and purified with phenol/chloroform extraction
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and precipitation by ethanol. Nucleic acid concentrations were measured using Qubit fluorimeter with
corresponding assay kits. For transcription, 1 U/µL T7-RNA-Polymerase, 1 fold buffer, 3.75 mM of
each rNTP, 10 mM DTT, 5 mM MgCl2 and 30 µg/mL DNA template was combined and incubated
at 37 ◦C for 5 h. To remove the DNA template, 0.1 U/µL DNase I with corresponding buffer was
added and incubated at 37 ◦C for 1 h. HCV-RNA was purified with “GeneJet RNA Cleanup and
Concentration Micro Kit” (Thermo Scientific, Waltham, MA, USA) according to the manufacturer’s
protocol. RNA integrity was confirmed by 0.8% agarose gel electrophoresis.
4.3. miR-122 Preparation
miR-122 oligonucleotides were obtained from Biomers. Mature miR duplexes were generated
by hybridizing equimolar amounts of guide (5′-(phos)UGGAGUGUGACAAUGGUGUUUG-3′) and
passenger strands in a thermocycler by slow temperature decrease from 90 to 4 ◦C (1 ◦C per minute).
4.4. Transfection
Huh-7.5 cells were seeded (5 × 103 cells/cm2) in 15 cm dishes and 12 well plates for ribosome
profiling as well as for control experiments. One day after seeding, 0.3 pmol double-stranded
miR-122/cm2 with or without 0.01 pmol HCV-RNA/cm2 were transfected with Lipofectamine 2000
(Invitrogen, Carlsbad, CA, USA). After 72 h, miR-122 duplexes were transfected again as before.
Ectopic miR-122 was supplemented to elevate miR-122 in the HuH-7.5 cells which is not as high as in
human primary liver cells [15,81]. Six days post transfection of HCV-RNA cells were lysed for qPCR,
western blot and ribosome profiling.
4.5. RT-qPCR
To evaluate HCV-RNA production, RT-qPCR was performed as described before [82]. Briefly,
cells were lysed with Trizol LS reagent (Ambion), and total RNA was extracted with chloroform and
precipitated with isopropanol. After DNase I treatment and RNA isolation, cDNA was produced
with the qScript Flex cDNA Kit (Quanta Biosciences, Beverly, MA, USA). qPCR was performed
using PerfeCTa SYBR Green FastMix (Quanta Biosciences). Intracellular miR-122 amounts were
quantified using the Taq-Man microRNA detection system (Thermo Scientific) for miRNA-122 as well
as miRNA-22 assay (for normalization).
4.6. Western Blot
HCV protein translation was verified by western blot. Transfected Huh-7.5 cells were harvested
with lysis buffer (10 mM Tris-HCl (pH 8), 140 mM NaCl, 0.025% NaN3, 1% Triton X-100) and incubated
for 20 min at 4 ◦C. After centrifugation lysates were mixed with SDS sample buffer, denatured
(90 ◦C) and loaded on a SDS-polyacrylamide gel. After blotting (0.8 mA/cm2), membranes were
blocked (5% milk powder in PBS). HCV NS3 protein was detected with 8G-2 antibody (Abcam,
1:500), core protein with C7-50 antibody (Thermo Scientific, 1:1000) and cellular GAPDH with 71.1
antibody (1:20,000, Sigma-Aldrich, St. Louis, MO, USA). As secondary antibody a goat-anti-mouse
IgG HOR (1:20,000, Life Technologies, Carlsbad, CA, USA) was used. Target proteins were detected
with SuperSignal West Femto Chemiluminescent Substrate (Thermo Scientific).
4.7. Ribosome Profiling and RNA-Seq Library Preparation
Library preparation was performed as described in [36] with additional modifications listed
below. Six days post transfection cells were washed with ice-cold PBS with cycloheximide (Sigma
Aldrich, 100 µg/mL) and harvested by adding 500 µL polysome lysis buffer (20 mM Tris–HCl (pH 7.5),
250 mM NaCl, 1.5 mM MgCl2, 1 mM DTT, 0.5% Triton X-100, 100 µg/mL, 20 U/mL TURBO DNase)
per 15 cm2 dish. Cells were not triturated with a gauge needle. After centrifugation, the supernatant
was divided into two parts for ribosome profiling and for total RNA library preparation. In one
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part RNA was quantified and digested with RNase I (100 U/3 A260) at room temperature for
50 min. To stop the digest, 40 U SUPERase*In per 100 U of RNase I was added. Sucrose gradient
ultracentrifugation was performed as described in [37] to extract and concentrate 80S ribosomal
protected RNA fragments. Gradients were fractionated and nucleic acid content measured at
260 nm. Fractions from the 80S monosome peaks were combined, phenol/chloroform extracted
and precipitated with isopropanol. For total RNA library preparation, at first Trizol LS reagent was
used according to the manufacturer’s protocol. After ethanol precipitation, alkaline fragmentation
was performed [35] for 60 min. From this point on, ribosome protected and fragmented total RNA
samples were treated the same way. Samples were loaded on 15% polyacrylamide TBE-urea gels
next to marker oligonucleotides, and fragments with a length of 26 to 34 nucleotides were excised.
RNA was extracted from gel fragments by adding 1 mL RNA extraction buffer and incubating
overnight at room temperature on a shaker. Library preparation was conducted as described before [36]
with the following modifications. On the one hand, the circularization reaction was performed for
two hours instead of one hour. For rRNA depletion, 14 µL sample reaction, 2 µL 20 × SSC, 2 µL
water and 2 µL rRNA subtraction oligonucleotide pool (D.E.A.) was combined. Prior to actual
PCR amplification with barcodes, optimal PCR cycle number was determined in 20 µL volume
reactions. Flanking sequences of PCR products were as follows: 5′AATGATACGGCGACCACCGA
GATCTACACTCTTTCCCTACACGACGCTCTTCCGATC (NEBNext Universal PCR Primer for
Illumina)—Insert—ACTGTAGGCACCATCAAT (Adapter)—AGATCGGAAGAGCACAC GTCTGAA
CTCCAGTCACXXXXXXATCTCGTATGCCGTCTTCTGCTTG (NEBNext Index Primer for Illumina).
Three replicates were carried out in parallel, RNA integrity verified on an Agilent BioAnalyzer and
sent for sequencing on a HiSeq 4000 at BGI Genomics (Shenzhen, China).
4.8. Preprocessing of Reads and Principal Component Analysis
To quickly assess the overall quality and usability of the sequencing data, a principal component
analysis (PCA) was performed. We therefore performed an initial mapping and differential expression
analysis (DEA).
DNA linker and subsequent Illumina Universal Adapter sequences were trimmed using cutadapt
(version: 1.15) (parameters: -O 1 -a ACTGTAGGCACCATCAATAGATCGGAAGAG). Short reads and
empty sequences were first removed using cutadapt (-m 25), and low quality reads were removed using
fastq_quality_filter from the FASTX Toolkit (0.0.14) (-q 14 -p 96). The final window size was determined
by cutadapt (-f fastq -q 28 -m 25 -M 34). Mapping of the remaining ribosome footprints against a
human rRNA dataset removed ribosomal derived sequences. Bowtie2 (2.3.4) (–seedlen 20 –un) served
for this filtering step, keeping only non-mapping reads. The human rRNA sequences were obtained
from various sources, including Ensembl BioMart (Ensembl Genes 91; GRCh38.p10; filters: gene type:
rRNA and Mt_rRNA), the SILVA rRNA database project [83] (with fasta headings “>id Homo sapiens
(human)”) and four additional rRNA sequences obtained from the RiboGalaxy project [84]. Reads
withstanding the filtering were subject to mapping against the human and HCV genomes using
bowtie2 (2.3.4) (-N 1 -L 22 -p 8 –no-unal -x <human_and_hepC_genome_index>). The human genome
sequence was obtained from Ensembl (Homo_sapiens.GRCh38.dna.primary_assembly.fa). Reads with
a MAPQ score below 20 were discarded. Finally the remaining reads were converted into BAM format
using samtools view (1.7) (-bS).
To generate a principal component analysis (PCA) we performed an initial differential expression
analysis (DEA) using R (3.4.2) and the Bioconductor package DESeq2 (1.18.2) [85]. A gene
model for the read counting step was derived from the human genome annotation in gtf format
(Homo_sapiens.GRCh38.90.gtf) as obtained from Ensembl. To generate the actual read counting
data, the two BioConductor packages GenomicAlignments (1.14.1) [86] and BiocParallel (1.12.0) were
utilized, extracting the count matrix from the previously generated BAM files. Genes without any
mapping reads were excluded from the analysis. Results as obtained from DESeq2’s plotPCA function
were visualized using ggplot2 (3.0.0).
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4.9. Trips-Viz Preprocessing and Mapping of Sequencing Data
The Trips-Viz (“TRanscriptome wide Information on Protein Synthesis VIZualized”; http://trips.
ucc.ie/) is a transcriptome browser designed to visualize Ribosome profiling and RNA-seq data at the
level of a single gene/transcript isoform [39]. Pre-processing and mapping pipeline is as follows:
The adapter sequences were removed from reads using cutadapt [87] (version 1.18) with the
following command: cutadapt -f fastq -a CTGTAGGCACCATCAAT –minimum-length=25 <input>.
fastq -o <output>.fastq.
Human rRNA sequences were retrieved from NCBI [88] with the following accessions: NR_003286,
NR_003287, NR_023363, NR_003285. Reads aligning to these sequences were then removed using
bowtie (version 1.0.1) with the following command: bowtie -v 3 –norc <path_to_rRNA_indices> -q
<input>.fastq –un <output>.fastq.
Bowtie [89] was then used to align the remaining reads to a transcriptome consisting of
a concatenation of the GENCODE [90] version 25 human transcriptome and the HCV genomic
sequence. The following command was used: bowtie –norc -a -m 100 -n 2 –seedlen 25
<path_to_transcriptome_indices> -q <input>.fastq <output>.sam.
The SAM file was then converted to a BAM file and sorted by readname using samtools [91]
(version 0.1.19) and the following commands: samtools view -b -S <input>.sam -o <output>.bam;
samtools sort -m 1G -n <input>.bam <output>.bam_sorted.
The genomic position(s) of each mapped read was determined, and if the read aligned to only one
genomic position it was classed as an unambiguously mapped read, otherwise the read was classed as
an ambiguously mapped read.
4.10. Differential Expression Analysis
For differential translation analysis using Trips-Viz [39], a principal transcript isoform was chosen
for each gene locus from the APPRIS database [92] (http://appris.bioinfo.cnio.es/) for GENCODE
version 25. The translation efficiency (TE) was calculated for each transcript by dividing Ribo-seq
counts (within CDS) by RNA-Seq counts (entire transcript). Differential gene expression plots use the
Z-score approach as described in [37] to determine which transcripts are up- or downregulated.
The Z-score represents how many standard deviations from the mean a particular transcript is.
However since it can be expected that more variance is in lowly expressed transcripts than in highly
expressed ones, transcripts were first placed into groups of similar expression levels. The geometric
mean of Ribo-Seq/RNA-Seq counts from control/infected samples was calculated for each transcript.
Transcripts were then sorted from lowest to highest geometric mean and grouped into bins of 300.
For each bin the TE fold change between control/infected samples was calculated and the mean and
standard deviation of fold changes in each bin was used to calculate a Z-score for each transcript.
Differential expression analyses were visualized by the Trips-Viz program package. Differential
gene expression plots were generated for pairwise comparisons of each of the three replicates of one
treatment (e.g., HCV) against each replicate of the other treatment (mock) in all possible combinations.
4.11. Metagene Analysis
A metagene profile was created for each Ribo-Seq read length from each dataset, centered on
the annotated start codons. The distance between the start codon and highest peak upstream of the
start codon plus 3 nucleotides was used as an offset from the 5′ end of each read to infer the ribosome
A-site. Metagene analyses were generated using the Trips-Viz transcriptome browser environment
(http://trips.ucc.ie/).
4.12. Single Transcript Comparison Plots
Single transcript comparison plots were generated using Trips-Viz (http://trips.ucc.ie/). Reads
were normalized by mapped reads, and windows were set to 25–40 nucleotides.
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4.13. Deposition of Sequences and of Expression Data
Sequence and expression analysis information is available in the NCBI GEO database: https:
//www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE127713.
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